{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe von Hippel‐Lindau (VHL) gene encodes a tumor suppressor protein, pVHL, that is central to cellular oxygen sensing. Under normoxic conditions, pVHL recognizes and binds to specific prolyl‐hydroxylated residues on hypoxia‐inducible factor (HIF) subunits—including HIF‐1α, HIF‐2α, and HIF‐3α—and directs them for polyubiquitylation and proteasomal degradation. This oxygen‐dependent regulation helps maintain appropriate expression of angiogenic (for example, vascular endothelial growth factor), metabolic, and chemokine genes, thereby preventing the inappropriate activation of hypoxic pathways. Loss or mutation of VHL leads to HIF stabilization even in the presence of oxygen—creating a “pseudohypoxic” state that drives angiogenesis, altered metabolism (such as reductive carboxylation in renal cancer cells), and aberrant expression of molecules like CXCR4—thereby promoting tumorigenesis in clear cell renal carcinoma and other VHL syndrome–associated neoplasms."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "16"}]}, {"type": "t", "text": "\n\nThe functions of pVHL extend well beyond HIF regulation. In addition to its canonical role, pVHL influences cellular architecture and signaling through HIF‐independent mechanisms. For example, pVHL interacts with and stabilizes microtubules, thereby promoting proper ciliogenesis and mitotic spindle orientation. It also modulates cell adhesion—regulating E‐cadherin levels—and participates in the stabilization of other key tumor suppressors such as p53. Moreover, pVHL directly or indirectly affects the degradation of signaling molecules including the NF‐κB activator Card9, beta‐catenin via the Jade–1 pathway, and even certain G protein–coupled receptors through a prolyl hydroxylation–dependent mechanism. Such multifaceted regulatory activities underscore the diverse biochemical interactions by which pVHL preserves cellular homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "26"}]}, {"type": "t", "text": "\n\nFinally, comprehensive clinical and genetic studies have established that alterations in VHL—ranging from point mutations and promoter hypermethylation to larger genomic rearrangements—are central to the pathogenesis of diverse tumors, including pheochromocytomas, hemangioblastomas, and especially clear cell renal carcinomas. Genetic screening and biomarker analyses have further refined risk stratification and illuminated genotype–phenotype correlations in both familial VHL disease and sporadic cancers. In addition, investigations combining imaging, circulating markers, and studies of interacting genetic partners (such as PBRM1) highlight the translational impact of deciphering VHL function and dysfunction, while observations in disorders like Chuvash polycythemia and chronic lymphocytic leukemia illustrate the broader physiological consequences of perturbed VHL pathways."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "27", "end_ref": "39"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Hartmut P H Neumann, Birke Bausch, Sarah R McWhinney, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Germ-line mutations in nonsyndromic pheochromocytoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa020152"}], "href": "https://doi.org/10.1056/NEJMoa020152"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12000816"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12000816"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Peter Staller, Jitka Sulitkova, Joanna Lisztwan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature01874"}], "href": "https://doi.org/10.1038/nature01874"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "13679920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/13679920"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Keiichi Kondo, Jeff Klco, Eijiro Nakamura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s1535-6108(02)00043-0"}], "href": "https://doi.org/10.1016/s1535-6108(02"}, {"type": "t", "text": "00043-0) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12086860"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12086860"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "William G Kaelin "}, {"type": "b", "children": [{"type": "t", "text": "Molecular basis of the VHL hereditary cancer syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Rev Cancer (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nrc885"}], "href": "https://doi.org/10.1038/nrc885"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12209156"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12209156"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jung-Hyun Min, Haifeng Yang, Mircea Ivan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1073440"}], "href": "https://doi.org/10.1126/science.1073440"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12004076"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12004076"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Wai-Ching Hon, Michael I Wilson, Karl Harlos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature00767"}], "href": "https://doi.org/10.1038/nature00767"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12050673"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12050673"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Keiichi Kondo, William Y Kim, Mirna Lechpammer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Biol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pbio.0000083"}], "href": "https://doi.org/10.1371/journal.pbio.0000083"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14691554"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14691554"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Mircea Ivan, Thomas Haberberger, David C Gervasi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.192342099"}], "href": "https://doi.org/10.1073/pnas.192342099"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12351678"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12351678"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "John D Gordan, Priti Lal, Vijay R Dondeti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2008.10.016"}], "href": "https://doi.org/10.1016/j.ccr.2008.10.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19061835"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19061835"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Paulo A Gameiro, Juanjuan Yang, Ana M Metelo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2013.02.002"}], "href": "https://doi.org/10.1016/j.cmet.2013.02.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23473032"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23473032"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "William G Kaelin "}, {"type": "b", "children": [{"type": "t", "text": "The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-06-1865"}], "href": "https://doi.org/10.1158/1078-0432.CCR-06-1865"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17255293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17255293"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Mindy A Maynard, Heng Qi, Jacky Chung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M208681200"}], "href": "https://doi.org/10.1074/jbc.M208681200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12538644"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12538644"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Michael Zimmer, Darrell Doucette, Naila Siddiqui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2004)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14985465"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14985465"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Malgorzata Zatyka, Nancy Fernandes da Silva, Steven C Clifford, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12097293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12097293"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "X Niu, T Zhang, L Liao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.266"}], "href": "https://doi.org/10.1038/onc.2011.266"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21725364"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21725364"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yosra Messai, Sophie Gad, Muhammad Zaeem Noman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Urol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.eururo.2015.11.029"}], "href": "https://doi.org/10.1016/j.eururo.2015.11.029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26707870"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26707870"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Alexander Hergovich, Joanna Lisztwan, Robert Barry, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb899"}], "href": "https://doi.org/10.1038/ncb899"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12510195"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12510195"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "David Z Qian, Sushant K Kachhap, Spencer J Collis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-05-4598"}], "href": "https://doi.org/10.1158/0008-5472.CAN-05-4598"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16951198"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16951198"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Olga Mikhaylova, Yiwen Stratton, Daniel Hall, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2012.02.019"}], "href": "https://doi.org/10.1016/j.ccr.2012.02.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22516261"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22516261"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Andrew J Evans, Ryan C Russell, Olga Roche, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00892-06"}], "href": "https://doi.org/10.1128/MCB.00892-06"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17060462"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17060462"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Jae-Seok Roe, Hyungsoo Kim, Soon-Min Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53 stabilization and transactivation by a von Hippel-Lindau protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2006.04.006"}], "href": "https://doi.org/10.1016/j.molcel.2006.04.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16678111"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16678111"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Claudio R Thoma, Ian J Frew, Christian R Hoerner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "pVHL and GSK3beta are components of a primary cilium-maintenance signalling network."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb1579"}], "href": "https://doi.org/10.1038/ncb1579"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17450132"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17450132"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Haifeng Yang, Yoji Andrew Minamishima, Qin Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2007.09.010"}], "href": "https://doi.org/10.1016/j.molcel.2007.09.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17936701"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17936701"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Vipul C Chitalia, Rebecca L Foy, Markus M Bachschmid, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb1781"}], "href": "https://doi.org/10.1038/ncb1781"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18806787"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18806787"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Liang Xie, Kunhong Xiao, Erin J Whalen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.2000444"}], "href": "https://doi.org/10.1126/scisignal.2000444"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19584355"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19584355"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Claudio R Thoma, Alberto Toso, Katrin L Gutbrodt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VHL loss causes spindle misorientation and chromosome instability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb1912"}], "href": "https://doi.org/10.1038/ncb1912"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19620968"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19620968"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Laurence Amar, Jérôme Bertherat, Eric Baudin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic testing in pheochromocytoma or functional paraganglioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2005.03.1484"}], "href": "https://doi.org/10.1200/JCO.2005.03.1484"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16314641"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16314641"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Michael L Nickerson, Erich Jaeger, Yangu Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-07-4921"}], "href": "https://doi.org/10.1158/1078-0432.CCR-07-4921"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18676741"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18676741"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Eamonn R Maher, Hartmut Ph Neumann, Stéphane Richard "}, {"type": "b", "children": [{"type": "t", "text": "von Hippel-Lindau disease: a clinical and scientific review."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Hum Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ejhg.2010.175"}], "href": "https://doi.org/10.1038/ejhg.2010.175"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21386872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21386872"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Massimo Mannelli, Maurizio Castellano, Francesca Schiavi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2008-2419"}], "href": "https://doi.org/10.1210/jc.2008-2419"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19223516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19223516"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "William G Kaelin "}, {"type": "b", "children": [{"type": "t", "text": "The von Hippel-Lindau tumor suppressor gene and kidney cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-sup-040025"}], "href": "https://doi.org/10.1158/1078-0432.CCR-sup-040025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15448019"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15448019"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Victor R Gordeuk, Adelina I Sergueeva, Galina Y Miasnikova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2003-07-2535"}], "href": "https://doi.org/10.1182/blood-2003-07-2535"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14726398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14726398"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Christoph A Karlo, Pier Luigi Di Paolo, Joshua Chaim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Radiology (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1148/radiol.13130663"}], "href": "https://doi.org/10.1148/radiol.13130663"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24029645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24029645"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Amrita M Nargund, Can G Pham, Yiyu Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2017.02.074"}], "href": "https://doi.org/10.1016/j.celrep.2017.02.074"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28329682"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28329682"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Carol Peña, Chetan Lathia, Minghua Shan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-09-3343"}], "href": "https://doi.org/10.1158/1078-0432.CCR-09-3343"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20651059"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20651059"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Tamotsu Kuroki, Francesco Trapasso, Sai Yendamuri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12839965"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12839965"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Zoran Erlic, Lisa Rybicki, Mariola Peczkowska, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-09-1237"}], "href": "https://doi.org/10.1158/1078-0432.CCR-09-1237"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19825962"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19825962"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Yves D Pastore, Jaroslav Jelinek, Sonny Ang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in the VHL gene in sporadic apparently congenital polycythemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2002-06-1843"}], "href": "https://doi.org/10.1182/blood-2002-06-1843"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12393546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12393546"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Asish K Ghosh, Tait D Shanafelt, Amelia Cimmino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2008-10-185686"}], "href": "https://doi.org/10.1182/blood-2008-10-185686"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19336759"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19336759"}]}]}]}